Quazomotide

Quazomotide is a WT1-derived class II peptide epitope (RSDELVRHHNMHQRNMTKL) that induces peptide-specific CD4+ T-cell responses. It functions as both an immunotherapeutic agent for active vaccination and an antineoplastic agent, with research applications in targeting WT1-positive cancers in vitro and in vivo.